NCT06030063 The Society for Obstetric Anesthesia and Perinatology Research Network General Anesthesia Registry
| NCT ID | NCT06030063 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Yale University |
| Condition | Cesarean Delivery |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,000 participants |
| Start Date | 2024-02-22 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,000 participants in total. It began in 2024-02-22 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The SOAP registry is a prospective, multicenter, electronic registry. The goal is to investigate the indications, mode of airway management, predisposing factors, and obstetric and anesthetic outcomes of pregnant patients who receive general anesthesia for cesarean delivery.
Eligibility Criteria
Inclusion Criteria: -Pregnant women aged 15-55 who have had a general anesthetic for Cesarean delivery
Contact & Investigator
Lisa Leffert, MD
PRINCIPAL INVESTIGATOR
Yale Univesrity
Frequently Asked Questions
Who can join the NCT06030063 clinical trial?
This trial is open to female participants only, aged 15 Years or older, up to 55 Years, studying Cesarean Delivery. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06030063 currently recruiting?
Yes, NCT06030063 is actively recruiting participants. Contact the research team at lisa.leffert@yale.edu for enrollment information.
Where is the NCT06030063 trial being conducted?
This trial is being conducted at Little Rock, United States, San Francisco, United States, Stanford, United States, Arvada, United States and 11 additional locations.
Who is sponsoring the NCT06030063 clinical trial?
NCT06030063 is sponsored by Yale University. The principal investigator is Lisa Leffert, MD at Yale Univesrity. The trial plans to enroll 5,000 participants.